Mirae Asset Global Etfs Holdings Ltd. Elevation Oncology, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 29,433 shares of ELEV stock, worth $9,124. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,433
Previous 28,029
5.01%
Holding current value
$9,124
Previous $16,000
56.25%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ELEV
# of Institutions
73Shares Held
33.2MCall Options Held
65KPut Options Held
4K-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.99MShares$1.86 Million0.1% of portfolio
-
Bml Capital Management, LLC Zionsville, IN5.89MShares$1.83 Million1.24% of portfolio
-
Tang Capital Management LLC San Diego, CA4.76MShares$1.48 Million0.08% of portfolio
-
Aisling Capital Management LP New York, NY2.83MShares$878,8220.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.59MShares$801,4180.0% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $7.22M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...